CAMBRIDGE, Mass. — September 10, 2025 — Leads & Copy — CAMP4 Therapeutics Corporation (Nasdaq: CAMP) announced it has entered into definitive securities purchase agreements for up to $100 million …
Our Lead Story
September 8, 2025 — Leads & Copy — Belite Bio, Inc (Nasdaq: BLTE), a clinical-stage drug development company, announced it has entered into securities purchase agreements with leading healthcare investors …
VANCOUVER, British Columbia — September 4, 2025 — BiotechReporter.news— Branded Legacy, Inc. (OTC: BLEG), through its subsidiary, BioLegacy Evaluative Group, has acquired a 22,000-square-foot commercial property in Vancouver, Canada, to …
Westford, Massachusetts — September 3, 2025 — Leads & Copy — The biotechnology market is projected to reach $6.64 trillion by 2032, growing at a CAGR of 14.96% from 2025, …
September 2, 2025 — Leads & Copy — CHARM Therapeutics has announced the closing of an oversubscribed Series B funding round, raising $80 million to advance its next generation menin …
ISELIN, N.J. — August 28, 2025 — Leads & Copy — Outlook Therapeutics, Inc. (Nasdaq: OTLK) announced the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) …